Evidence-based recommendations on risankizumab (Skyrizi) for previously treated moderately to severely active Crohn's disease in people 16 years and over....
Chirurgická léčba je součástí péče o pacienty s idiopatickými střevními záněty (IBD). Během prvního roku trvání Crohnovy nemoci (CN) je pravděpodobnost operace 20–40 %, do 10 let je operováno 30–70 % nemocných a po 15 letech od diagnózy 70–90 % nemocných. V prvních deseti let...
The incidence and prevalence of Crohn's disease (CD) is rising globally. Patients with moderate to severe CD are at high risk for needing surgery and hospitalization and for developing disease-related complications, corticosteroid dependence, and serious infections. Optimal management of outpatients with...
Panaccione, R;
Steinhart, A. H;
Bressler, B;
Khanna, R;
Marshall, J. K;
Targownik, L;
Bitton, A;
Borgaonkr, M;
Chauhan, U;
Halloran, B;
Jones, J;
Kennedy, E;
Leontiadis, G. I;
Jr Loftus, E. V;
Meddings, J;
Moayyedi, P;
Plamondon, S.
Crohn's disease (CD) is a lifelong illness with substantial morbidity, although new therapies and treatment paradigms have been developed. We provide guidance for treatment of ambulatory patients with mild to severe active luminal CD. We performed a systematic review to identify published studies of the ...
This guideline covers the management of Crohn's disease in children, young people and adults. It
aims to reduce people's symptoms and maintain or improve their quality of life....
Mack, David R;
Benchimol, Eric I;
Critch, Jeff;
de Bruyn, Jennifer;
Tse, Frances;
Moayyedi, Paul;
Church, Peter;
Deslandres, Colette;
El-Matary, Wael;
Huynh, Hien;
Jantchou, Prévost;
Lawrence, Sally;
Otley, Anthony;
Sherlock, Mary;
Walters, Thomas;
Kappelman, Michael D;
Sadowski, Dan;
Marshall, John K;
Griffiths, Anne.
We aim to provide guidance for medical treatment of luminal Crohn’s disease in children. We performed a systematic search of publication databases to identify studies of medical management of pediatric Crohn’s disease. Quality of evidence and strength of recommendations were rated according to the G...
Generar recomendaciones informadas en la evidencia para el tratamiento de los pacientes con enfermedad de Crohn. Apoyar al tratamiento oportuno y seguro de los pacientes de enfermedad de Crohn considerando las minimización de secuelas y la hospitalización. Apoyar a los tomadores de decisiones a formula...
Nguyen, GC;
Seow, CH;
Maxwell, C;
Huang, V;
Leung, Y;
Jones, J;
Leontiadis, GI;
Tse, F;
Mahadevan, U;
van der Woude, CJ.
"BACKGROUND & AIMS:
The management of inflammatory bowel disease (IBD) poses a particular challenge during pregnancy because the health of both the mother and the fetus must be considered.
METHODS:
A systematic literature search identified studies on the management of IBD during pregnancy. The quality o...
Immunosuppresseurs/administration et posologie,
Rectocolite hémorragique,
Maladie de Crohn,
Substitution de médicament,
Gastroentérologie,
Services de santé maternelle,
Prise en charge préconceptionnelle,
Complications de la grossesse,
Appréciation des risques,
Facteurs de risque,
Résultat thérapeutique,
Maladies inflammatoires intestinales,
Maladie de Crohn/diagnostic,
Maladie de Crohn/thérapie,
Complications de la grossesse/diagnostic,
Complications de la grossesse/thérapie,
Immunosuppresseurs/effets indésirables,
Rectocolite hémorragique/diagnostic,
Rectocolite hémorragique/thérapie
Facteur de nécrose tumorale alpha,
Mercaptopurine,
Azathioprine,
Méthotrexate,
Maladie de Crohn,
Gastroentérologie,
Mercaptopurine/usage thérapeutique,
Méthotrexate/usage thérapeutique,
Induction de rémission,
Maladie de Crohn/traitement médicamenteux,
Facteur de nécrose tumorale alpha/antagonistes et inhibiteurs
This guideline covers using colonoscopy to check for signs of bowel cancer in people aged 18 and over with ulcerative colitis or Crohn’s disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to prevent cancer and prolong life by offering advice on identifying early b...
